RxDoctor Payments Data

Amber Stola, MD

Critical Care Medicine · Fargo, NDNPI 1194218560

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.2%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 67.0% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $7,530, more than ten times the $13 reported in 2019.

$11,409in general payments, 2019–2025

Across 58 payments — averaging $196.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Medical Device Business Services, Inc.$2K
  • Medtronic$1K
  • Johnson & Johnson$123
  • United Therapeutics Corporation$20
  • Inspire Medical Systems, Inc.$16
  • plus $13 from 1 others

What the payments were for

  • Travel & lodging$5,72750%
  • Food & beverage$1,68215%
  • Education$4,00035%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few critical care medicine providers in North Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$18,314
Medicare patients
92
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Spiriva RespimatTiotropium Bromide14$9,205
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$7,685
Breo ElliptaFluticasone/Vilanterol12$6,456
Albuterol Sulfate HfaAlbuterol Sulfate41$1,247
Montelukast Sodium15$132

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →